Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics of 283 patients starting a low IFNB dose.

From: Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective?

  Patients switching to high IFNB dose n = 121 Patients remaining on low IFNB dose n = 162 Pooled n = 283
Male gender, n (%) 39 (32.2) 49 (30.2) 88 (31.1)
Age, years 31.5 (8.5) 32.8 (9.8) 32.2 (9.2)
MS duration, years 5.4 (5.3) 6.1 (5.9) 5.8 (5.7)
Annualised relapse rate pre-IFNB 1.00 (0.74) 0.92 (0.76) 0.95 (0.75)
EDSS score, median [range] 1.5 [0 - 3.5] 1.5 [0 - 3.5] 1.5 [0 - 3.5]
Active MRI scan, n (%) 65 (53.7) 69 (42.6) 134 (47.3)
  1. All value are expressed as mean (standard deviation), unless indicated otherwise.
  2. All p-values are > 0.05